Amgen Archives - DelveInsight

Amgen

Rare diseases challenges | Rare diseases clinical trials, incidence, and funding
The Paradox of Rare: Chalking out Challenges in the Rare Disease Market

How is a Rare disease defined? Well, it depends on the geography in question, since there is no universal definition, even so, the definition revolves around the point of prevalence or incidence o...


Small Cell Lung Cancer Market | SCLC Market
Small Cell Lung Cancer Market Booms with an Influx of Companies and Robust Pipeline

As per DelveInsight, the Small cell lung cancer market size is expected to increase at a CAGR of 15.2% during the study period (2017–30) attributing to a rich pipeline, healthcare spending, improv...


pharma-news
Alnylam’s lumasiran results; AZ’s oncology drug; Astellas Roxadustat; Evotec’s partnership with ABL

Alnylam Pharmaceuticals has released the Phase III results of the clinical trial ILLUMINATE-A evaluating lumasiran for Primary Hyperoxaluria Type 1Primary Hyperoxaluria Type 1 (PH1) is a rare ...


Pharma News
Thumbs down to NKTR-181, Lilly expands its insulin armamentarium

The US FDA has voted down Nektar Therapeutics’ opioid painkiller NKTR-181, designed to treat lower back pain. The FDA’s Anesthetic and Analgesic Drug Products Advisory Committee and the D...


Pharma News
AstraZeneca tops the first Pharma Invention Index; Amgen to buy 20.5% stake in a Chinese pharmace...

Amgen has announced to purchase 20.5% of the stake in Chinese-American drug company BeiGene.As per the deal signed, Amgen will develop and commercialize around two dozen of its on-market as w...


Cluster headache
Lilly overtakes rivals with its Cluster Headache approval

In layman’s language, Cluster headache is a headache disorder that occurs in cyclical patterns. The term cluster headache itself defines the condition that these attacks occur in groups, or “clust...


World Pharma News
The Business Cocktail

Merck decides to acquire Peloton Therapeutics, fortifying Oncology pipelineMerck is ready to buy Peloton Therapeutics for USD 1.1 million. The companies have entered into a definitive agreeme...


Notizia
Notizia

Roche's takes a step- forward to treat Huntington's diseaseA new drug co-developed by Roche and Ionis Pharmaceuticals can be a potential candidate to treat Huntington's disease. RG6042 which i...


the business cocktail
AgomAb Therapeutics raises $23.5M; Allergan’s eye drug; Good news for the patients; Dyne Th...

AgomAb Therapeutics raises USD 23.5 million for its agomAbsA Belgian biotherapeutics company AgomAb Therapeutics which has been in a long run of making agonistic antibodies has secured USD 23....


Gilead
Tetra, Shionogi sign deal; Amgen remunerates; Gilead’s fibrotic disease deal

Tetra, Shionogi sign USD 40 Million deal for Alzheimer’s disease and fragile X syndromeTetra Discovery Partners is collaborating with Shionogi to progress its PDE4-targeting drug in ...


Editor's Pick
Discover How Learning Disability Treatment Landscape is Evolving with the Eme...

A Learning Disability (LD) is a neurological condition resulting from genetic and neuro...

Development of Gene Therapies in Dermatology

What is Gene Therapy and Is the Skin Suitable for Gene Therapy? Since its first discove...

Mapping the Increasing Burden of Heart Failure: What Does it Bring for Health...

Heart failure (HF), also referred to as Congestive Heart failure (CHF), is a condition ...

Bone Metastasis Market: A Debilitating Consequence for Many Tumors

In advanced cancer patients, the most common site for the occurrence of metastasis is c...

Evaluating the Role of Digital Therapeutics as an Alternative to Conventional...

Depression is a mental condition characterized by prolonged series of poor moods, loss ...

ASCO Conference 2021
ASCO Conference 2021

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.